ARCHIVES

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

Leukemia Biology Study Needed To Improve Results, Pinkel Says In Karnfsky Lecture

April 7, 1978

States Join Suit Alleging Amgen Offered Illegal Kickback To Doctors For Aranesp

November 6, 2009

In Brief: ONS Invites Proposals For Research On Hazards Of Chemotherapy; UTSCC Adopts Code Of Ethics

August 31, 1984

Ethics Advisory Board to Consider Compensation Issue

September 7, 1979

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

September 29, 2006

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000